Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima, Anna Jankowska, Michael A. McDevitt, et al.
Blood (2011) Vol. 117, Iss. 21, pp. e198-e206
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

The role of mutations in epigenetic regulators in myeloid malignancies
Alan H. Shih, Omar Abdel‐Wahab, Jay P. Patel, et al.
Nature reviews. Cancer (2012) Vol. 12, Iss. 9, pp. 599-612
Closed Access | Times Cited: 650
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
Myunggon Ko, Hozefa S. Bandukwala, Jungeun An, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 35, pp. 14566-14571
Open Access | Times Cited: 553
The promise of whole-exome sequencing in medical genetics
Bahareh Rabbani, Mustafa Tekin, Nejat Mahdieh
Journal of Human Genetics (2013) Vol. 59, Iss. 1, pp. 5-15
Open Access | Times Cited: 479
The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
Zachary R. Hunter, Lian Xu, Guang Yang, et al.
Blood (2013) Vol. 123, Iss. 11, pp. 1637-1646
Open Access | Times Cited: 435
Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation
Lulu Hu, Ze Li, Jingdong Cheng, et al.
Cell (2013) Vol. 155, Iss. 7, pp. 1545-1555
Open Access | Times Cited: 393
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, et al.
Nature Genetics (2016) Vol. 49, Iss. 2, pp. 204-212
Open Access | Times Cited: 381
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Hideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, et al.
Blood (2012) Vol. 119, Iss. 14, pp. 3203-3210
Open Access | Times Cited: 364
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola, Matteo Giovanni Della Porta, Luca Malcovati
Blood (2013) Vol. 122, Iss. 25, pp. 4021-4034
Open Access | Times Cited: 329
Somatic SETBP1 mutations in myeloid malignancies
Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, et al.
Nature Genetics (2013) Vol. 45, Iss. 8, pp. 942-946
Open Access | Times Cited: 248
TET proteins and the control of cytosine demethylation in cancer
Laurianne Scourzic, Enguerran Mouly, Olivier Bernard
Genome Medicine (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 225
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Susan Branford, Paul Wang, David T Yeung, et al.
Blood (2018) Vol. 132, Iss. 9, pp. 948-961
Open Access | Times Cited: 179
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60
Loss of Asxl1 leads to myelodysplastic syndrome–like disease in mice
Jiapeng Wang, Zhaomin Li, Yongzheng He, et al.
Blood (2013) Vol. 123, Iss. 4, pp. 541-553
Open Access | Times Cited: 166
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Bartlomiej Przychodzen, Andrés Jerez, Kathryn M Guinta, et al.
Blood (2013) Vol. 122, Iss. 6, pp. 999-1006
Open Access | Times Cited: 156
STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients
Andrés Jerez, Michael J. Clemente, Hideki Makishima, et al.
Blood (2013) Vol. 122, Iss. 14, pp. 2453-2459
Open Access | Times Cited: 146
Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies
Hui Yang, Stefan Kurtenbach, Ying Guo, et al.
Blood (2017) Vol. 131, Iss. 3, pp. 328-341
Open Access | Times Cited: 146
Myeloid malignancies: mutations, models and management
Anne Murati, Mandy Brecqueville, Raynier Devillier, et al.
BMC Cancer (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 138
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
Mathias Schmidt, Jenny Rinke, Vivien Schäfer, et al.
Leukemia (2014) Vol. 28, Iss. 12, pp. 2292-2299
Open Access | Times Cited: 132
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
Elisabeth Bolton-Gillespie, Mirle Schemionek, Hans‐Ulrich Klein, et al.
Blood (2013) Vol. 121, Iss. 20, pp. 4175-4183
Open Access | Times Cited: 123
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
Chunzhi Zhang, Lynette M. Moore, Xia Li, et al.
Neuro-Oncology (2013) Vol. 15, Iss. 9, pp. 1114-1126
Open Access | Times Cited: 123
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Susan Branford, Dennis Dong Hwan Kim, Jane F. Apperley, et al.
Leukemia (2019) Vol. 33, Iss. 8, pp. 1835-1850
Open Access | Times Cited: 123
The role of ASXL1 in hematopoiesis and myeloid malignancies
Shuhei Asada, Takeshi Fujino, Susumu Goyama, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 13, pp. 2511-2523
Open Access | Times Cited: 111
PRPF8 defects cause missplicing in myeloid malignancies
Amina Kurtović-Kozarić, B Przychodzen, Jagjit Singh, et al.
Leukemia (2014) Vol. 29, Iss. 1, pp. 126-136
Open Access | Times Cited: 109
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, et al.
Blood (2016) Vol. 129, Iss. 1, pp. 38-47
Open Access | Times Cited: 106
Genomic determinants of chronic myelomonocytic leukemia
Bhumika J. Patel, B Przychodzen, Swapna Thota, et al.
Leukemia (2017) Vol. 31, Iss. 12, pp. 2815-2823
Open Access | Times Cited: 95
Page 1 - Next Page

Scroll to top